CoreLine Soft Co

CoreLine Soft Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is -57.47 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -73.48 % — a change of -21.80% (higher).

EBIT/Assets

-57.47 %

YoY

-21.80%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of CoreLine Soft Co is 2024 -57.47 % . Operating Income to Assets Ratio (EBIT/Assets) of CoreLine Soft Co was 2023 -73.48 % . It decreases by -21.80% higher compared to the previous year.

The CoreLine Soft Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2020
-33.59 KRW
Jan 1, 2021
-50.39 KRW
Jan 1, 2022
-181.49 KRW
Jan 1, 2023
-73.48 KRW
Jan 1, 2024
-57.47 KRW
The CoreLine Soft Co EBIT/Assets history
YEAREBIT/AssetsYoY
-57.47 %-21.80%
-73.48 %-59.51%
-181.49 %+260.16%
-50.39 %+50.04%
-33.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

Operating Income to Assets Ratio (EBIT/Assets) of CoreLine Soft Co is -57.47 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of CoreLine Soft Co changed from -73.48 % to -57.47 %, representing a -21.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s CoreLine Soft Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co